Give dementia drug users a break

Deprescribing dementia drugs can be considered for people who have been using them for a year, draft NHMRC guidelines say.

A trial withdrawal of drugs such as donepezil, rivastigmine, galantamine and memantine may identify people for whom cognitive benefits have ceased, and prevent side effects, the advice states.

Some patients who have been using them long-term at full dosage may be able to stop with “minimal clinically